SI
GSK icon

SII Investments’s GSK GSK Stock Holding History

SII Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-15,597
Closed -$692K – 125
2017
Q4 		$692K Buy
15,597
+11,448
+276% +$529K 0.07% 200
2017
Q3 		$209K Sell
4,149
-14,361
-78% -$729K 0.01% 542
2017
Q2 		$999K Sell
18,510
-315
-2% -$16.8K 0.06% 219
2017
Q1 		$989K Sell
18,825
-3,569
-16% -$181K 0.07% 200
2016
Q4 		$1.08M Buy
22,394
+811
+4% +$40.1K 0.08% 188
2016
Q3 		$1.17M Sell
21,583
-5,289
-20% -$290K 0.09% 167
2016
Q2 		$1.46M Buy
26,872
+1,414
+6% +$74.5K 0.12% 153
2016
Q1 		$1.28M Buy
25,458
+17,184
+208% +$856K 0.12% 162
2015
Q4 		$413K Sell
8,274
-6,440
-44% -$328K 0.05% 285
2015
Q3 		$719K Buy
14,714
+8,685
+144% +$452K 0.08% 225
2015
Q2 		$304K Sell
6,029
-3,306
-35% -$186K 0.04% 387
2015
Q1 		$536K Sell
9,335
-352
-4% -$20.2K 0.06% 274
2014
Q4 		$523K Buy
9,687
+3,727
+63% +$209K 0.07% 254
2014
Q3 		$342K Buy
5,960
+238
+4% +$14.6K 0.05% 341
2014
Q2 		$381K Buy
5,722
+148
+3% +$10K 0.05% 309
2014
Q1 		$368K Buy
5,574
+416
+8% +$28.1K 0.07% 273
2013
Q4 		$344K Buy
5,158
+76
+1% +$4.93K 0.06% 295
2013
Q3 		$320K Sell
5,082
-169
-3% -$10.9K 0.08% 239
2013
Q2 		$327K Buy
+5,251
New +$333K 0.07% 266

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SII Investments's GSK Position: Q1 2018 in Review

SII Investments sold out of GSK (GSK) in Q1 2018, closing a stake of 15,597 shares — an estimated $692K sold.

SII Investments first reported a position in GSK in Q2 2013 and held it in 19 quarters. The position peaked at $1.46M in Q2 2016. 778 funds tracked by Wall St. Rank hold GSK as of Q1 2018.

  • SII Investments reported no remaining GSK position as of Q1 2018 after selling out during the quarter.
  • SII Investments sold 15,597 GSK shares in Q1 2018, an estimated $692K.
  • SII Investments first reported a position in GSK in Q2 2013 and held it in 19 quarters.
  • SII Investments's GSK position peaked at $1.46M in Q2 2016.
  • 778 funds tracked by Wall St. Rank held GSK as of Q1 2018.

Based on SII Investments's 13F filing for Q1 2018.